Werkgroep Cardiologische centra Nederland

THEMIS (Completed)

A multinational, randomised, double-blind, placebo-controlled trial to evaluate the effect of ticagrelor 90mg twice daily on the incidence of cardiovascular death, myocardial infarction or stroke in patients with type 2 diabetes mellitus
Medicine
ticagrelor
Population
Diabetes mellitus
Phase
III
Starting year
2015
More information
ClinicalTrials.gov

Director of Study

dr. S.H.K. The (Cardioloog)
Emmen, Treant Zorggroep, locatie Scheper